[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ekso Bionics Holdings Inc 101 GLACIER POINT SUITE A SAN RAFAEL CA 94901 USA

www.eksobionics.com Employees: 55 P: 510-984-1761

Sector:

Medical

Description:

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.

Key Statistics

Overview:

Market Capitalization, $K 39,162
Enterprise Value, $K 40,802
Shares Outstanding, K 3,563
Float, K 3,318
% Float 93.10%
Short Interest, K 215
Short Float 6.04%
Days to Cover 2.32
Short Volume Ratio 0.63
% of Insider Shareholders 6.90%
% of Institutional Shareholders 6.42%

Financials:

Annual Sales, $ 12,800 K
Annual Net Income, $ -11,700 K
Last Quarter Sales, $ 3,140 K
Last Quarter Net Income, $ -4,670 K
EBIT, $ -13,330 K
EBITDA, $ -11,760 K

Growth:

1-Year Return 65.16%
3-Year Return -50.83%
5-Year Return -87.17%
5-Year Revenue Growth 44.14%
5-Year Earnings Growth 79.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.56 on 02/23/26
Next Earnings Date 05/04/26 [--]
Earnings Per Share ttm -5.14
EPS Growth vs. Prev Qtr -188.89%
EPS Growth vs. Prev Year 25.68%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 06/02/25

EKSO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -110.52%
Return-on-Assets % -50.71%
Profit Margin % -91.41%
Debt/Equity 0.31
Price/Sales 3.02
Price/Cash Flow N/A
Price/Book 3.15
Book Value/Share 3.45
Interest Coverage -36.74
60-Month Beta 0.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.